SEC Slams OTC Link LLC with $575,000 Penalty and Censure Over Nearly a Decade of Regulation SCI Breaches
WASHINGTON, D.C. — In a decisive enforcement action underscoring the federal government’s zero-tolerance policy toward structural cyber-neglect in market infrastructure, the U.S. Securities and Exchange Commission (SEC) announced a formal censure and a $575,000 civil penalty against New York-based broker-dealer OTC Link LLC.
The penalty concludes a settled administrative proceeding targeting the firm’s persistent, long-term failures to comply with Regulation Systems Compliance and Integrity (Regulation SCI). According to regulatory findings, the alternative trading system (ATS) operator routinely ignored repeated warnings from commission examiners over an eight-and-a-half-year period, leaving critical vulnerabilities unaddressed in systems designed to support the backbone of over-the-counter (OTC) securities trading in the United States.
Main Facts of the Enforcement Action
The core of the SEC’s administrative order centers on systemic deficiencies within OTC Link ATS, an electronic alternative trading system operated by OTC Link LLC that facilitates the trading of over-the-counter equities. Between August 2016 and March 2025, the firm allegedly operated in systemic violation of Regulation SCI, a critical post-financial-crisis rule set implemented to strengthen the technology infrastructure of the U.S. securities markets.
Specifically, the SEC found that OTC Link LLC failed to establish, maintain, and enforce comprehensive written policies and procedures mandated by law. These foundational oversights touched upon several high-risk operational pillars:
- System Security: Inadequate safeguards to protect core trading architectures from unauthorized access or malicious interference.
- Access Control: Deficient protocols governing who and what could interact with the platform’s core and indirect SCI systems.
- Application Vulnerability Management: A chronic inability to systematically identify, test, patch, and remediate software and network vulnerabilities.
Rather than treating these policy omissions as minor administrative oversights, the commission emphasized the willful nature of the non-compliance. During the nearly decade-long window, examiners from the SEC’s Division of Examinations conducted routine and targeted reviews of OTC Link ATS. On multiple occasions, examiners explicitly flagged required policies and procedures that were either missing entirely, languishing indefinitely in "draft" status, or left completely unenforced.
Despite these direct alerts from federal regulators, OTC Link LLC repeatedly failed to implement prompt corrective actions. To settle the charges, the firm agreed to a cease-and-desist order, a formal censure, and a $575,000 civil money penalty, without admitting or denying the SEC’s findings.
Chronology of Regulatory Oversight and Failures
The timeline established in the SEC’s settled order highlights a pattern of prolonged inaction that ultimately triggered enforcement intervention:
- August 2016: The statutory clock for the violations begins. From this point forward, the firm was legally obligated under Regulation SCI to maintain robust, tested, and actively enforced written policies concerning its trading systems’ capacity, integrity, resiliency, availability, and security.
- 2017–2023 (The Examination Cycles): Over successive years, staff members from the SEC’s Division of Examinations conducted multiple routine and specialized reviews of OTC Link ATS. During nearly every examination cycle, field inspectors discovered that required governance documentation was either absent or remained unfinalized in draft formats. Crucially, these shortcomings were formally communicated to the firm’s leadership and compliance teams.
- March 2025: The endpoint of the prolonged violation window. By this time, despite years of explicit regulatory warnings, critical gaps in application vulnerability management, testing, and remediation remained uncorrected.
- September 22, 2026: The SEC officially hands down its administrative order, marking the public conclusion of the enforcement action with the imposition of the censure, cease-and-desist mandates, and the $575,000 financial penalty.
Supporting Data and Regulatory Framework
To fully understand the weight of the SEC’s action against OTC Link LLC, one must examine the specific mechanics of Regulation SCI and the statutory rules governing alternative trading systems.
Adopted by the commission in late 2014, Regulation SCI was designed to reduce the frequency and impact of technological disruptions in the U.S. securities markets. It applies to "SCI entities," which include self-regulatory organizations (such as stock exchanges and FINRA), alternative trading systems that meet specific volume thresholds, clearing agencies, and plan processors.
The framework requires these entities to establish written policies and procedures reasonably designed to ensure their core technology systems possess adequate capacity, integrity, resiliency, availability, and security.
In the case of OTC Link LLC, the SEC’s order specifically cites violations of three core provisions under Rule 1001 of Regulation SCI:
- Rule 1001(a)(1): Mandates that each SCI entity shall establish, maintain, and enforce written policies and procedures reasonably designed to ensure that its SCI systems—and, for security standards, its indirect SCI systems—have levels of capacity, integrity, resiliency, availability, and security adequate to maintain the entity’s operational capability and promote the maintenance of fair and orderly markets. OTC Link LLC was found to have severely lacked these baseline parameters.
- Rule 1001(a)(2): Requires SCI entities to periodically review the effectiveness of the policies and procedures required by paragraph (a)(1) and to take prompt action to remedy any deficiencies. The firm’s failure to act upon repeated examination warnings directly breached this statutory duty.
- Rule 1001(a)(3): Stipulates that policies and procedures must be updated and maintained in alignment with technological and regulatory developments. By leaving core security and vulnerability policies in draft formats for years, OTC Link LLC violated this mandate.
The $575,000 civil penalty, while modest compared to penalties levied against Wall Street giants for multi-billion-dollar market manipulations, reflects a calculated calibration by the SEC. It targets a mid-sized broker-dealer operating a specialized niche market, carrying enough financial weight to signal that ignoring examination findings carries a concrete cost.
Official Responses and Regulatory Posture
The enforcement division made it clear that the penalty was driven less by a catastrophic market crash or a specific data breach, and more by the firm’s blatant disregard for the regulatory process itself.
"OTC Link’s continual failure to remediate deficiencies even after they were repeatedly flagged by Division of Examinations staff reflects a disregard for their findings and the overall examinations process and justifies a meaningful penalty," stated Laura D’Allaird, Chief of the Division of Enforcement’s Cyber and Emerging Technologies Unit.
D’Allaird’s remarks serve as a direct warning shot to the broader financial technology and broker-dealer community. The message from the SEC is unequivocal: the examination process is not a consultative advisory service where regulatory feedback can be ignored or delayed indefinitely.
"All SCI entities are expected to take their regulatory responsibilities seriously and promptly fix issues when they’re identified," D’Allaird added, emphasizing that the Cyber and Emerging Technologies Unit remains hyper-focused on operational resilience and compliance posture across all automated trading venues.
Representatives for OTC Link LLC have not issued a broader public relations statement beyond agreeing to the terms of the settlement, which allows the firm to bypass a protracted courtroom battle while accepting the financial and administrative penalties.
Broader Implications for Alternative Trading Systems and Cyber Governance
The SEC’s action against OTC Link LLC holds profound implications for the over-the-counter market ecosystem and the wider landscape of electronic trading venues. As traditional exchanges and alternative trading systems become increasingly digitized and interconnected, regulatory scrutiny over backend infrastructure has intensified.
1. The End of the "Drafting" Loophole
For years, a common compliance vulnerability across the fintech and broker-dealer landscape has been the reliance on "perpetual drafts"—policies written on paper to satisfy a theoretical requirement, but never formally finalized, tested, or enforced. By penalizing OTC Link LLC specifically for leaving critical application vulnerability and access control policies in draft form, the SEC has signaled that paper compliance will no longer suffice. Policies must be living, operationalized frameworks.
2. Amplifying the Power of the Division of Examinations
This enforcement action bridges a crucial gap between the SEC’s Examination staff and its Enforcement division. Often, firms view examination deficiency letters as a to-do list with a flexible timeline. By weaponizing repeated, unaddressed examination findings as the foundational proof of a willful regulatory breach, the SEC has given its examination reports significantly more teeth. Financial institutions are now on notice that failing to remediate exam findings can rapidly escalate into formal enforcement actions and financial penalties.
3. Heightened Scrutiny on Over-the-Counter Markets
While high-frequency trading firms and national securities exchanges like NASDAQ and the NYSE frequently dominate headlines regarding technological resilience, the over-the-counter market plays a vital, albeit less visible, role in capital formation and retail investing. Platforms like OTC Link ATS handle millions of transactions in microcap stocks, foreign equities, and unlisted securities. Ensuring the cybersecurity and operational resiliency of these alternative venues is paramount to protecting retail investors who frequently access these liquidity pools.
Conclusion
As cybersecurity threats evolve and federal regulators place an ever-increasing emphasis on operational resilience, the case of SEC v. OTC Link LLC will likely be cited as a textbook example of how not to handle regulatory feedback. For broker-dealers and alternative trading systems operating under Regulation SCI, the message is clear: compliance is an active, ongoing obligation, and ignoring the watchful eye of federal examiners is a gamble that ultimately comes with a heavy price.
